FDA Inspection 1283660 — Aishah Jalan Ibrahim
The FDA completed an inspection of Aishah Jalan Ibrahim on September 26, 2025 in Kuantan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 26, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kuantan (Malaysia)
Additional Details
Clinical Investigator (CI)